iShares Neuroscience & Healthcare (IBRN) 50 Day Lows
About this Chart's Calculations for Neuroscience
Expectancy calculation (win % x average win) - (loss % x average loss): (100% * 5.79%) - (0% * 0%) = 5.79%. To be a profitable trader you need to trade with a positive value for expectancy.
The Sharpe Ratio calculation assumes a risk free return rate of 2% per calendar year. Ideally the ratio should be a positive number. A higher positive number indicates the strategy has a more attractive risk adjusted rate of return.
50 Day Lows - Profit Probability Projections
This table summarises how long it would take after buying the ETF at the 50 day lows to reach the specified percentage return. Note that past performance is not a guarantee of future performance. The calculations exclude the exceptionally volatile month of March 2020. Calculations also exclude dividends and other distributions to shareholders.
| Date | Days to Reach Profit Target | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5% | 6% | 7.5% | 10% | 20% | ||||||
| 2025 | 136 | 176 | 182 | 213 | ||||||
| 2024 | 92 | 194 | 196 | 258 | ||||||
| 2023 | 100 | 108 | 111 | 79 | ||||||
| Avg. Days | 109 | 159 | 163 | 183 | ||||||
| CAGR | 17.7% | 18.1% | 23.8% | 43.9% | ||||||
50 Day Lows - Backtest Trading Summary
This table summarises how profitable it would have been to have bought this ETF at each 50 day low. Hover over the icons to see more details of the particular trade, including the maximum percentage drawdown and how long it took to reach the desired percentage profit.
Key:
= profit point not achieved.
= profit point achieved with CAGR above 15%.
= profit point achieved with CAGR of between 5% and 15%.
= profit point achieved but CAGR was less than 5%.
| Signal Date | Price | Performance (mouseover for details) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5% | 6% | 7.5% | 10% | 20% | |||||||
| 03 March 2026 | $31.25 | ||||||||||
| 31 March 2025 | $22.31 | ||||||||||
| 25 February 2025 | $24.90 | ||||||||||
| 18 December 2024 | $25.21 | ||||||||||
| 18 April 2024 | $23.10 | ||||||||||
| 18 March 2024 | $25.10 | ||||||||||
| 18 October 2023 | $20.40 | ||||||||||
| 15 September 2023 | $22.14 | ||||||||||
| 08 August 2023 | $23.34 | ||||||||||
| 05 July 2023 | $24.05 | ||||||||||
| 22 February 2023 | $25.05 | ||||||||||
50 Day Lows - Compound Annual Growth Rate (CAGR) Summary
Compound Annual Growth Rate (CAGR) shows the annual percentage performance had the investment grown at the same rate over one year. Cross reference the figures in the tables below with the backtesting results tables above to see how long it took to achieve profitability after buying this ETF at the specific 50 day low. A red (empty) table cell shows that the specific profit point has not yet been achieved. Calculations exclude dividends or other distributions this fund may distribute to fund holders.
| Date | Price | Gains / CAGR | ||||||
|---|---|---|---|---|---|---|---|---|
| 5% | 6% | 7.5% | 10% | 20% | ||||
| 03 March 2026 | $31.25 | |||||||
| 31 March 2025 | $22.31 | 30.5 | 35.5 | 21.6 | 27.3 | 43.9 | ||
| 25 February 2025 | $24.90 | 9.1 | 10.3 | 12.9 | 17.1 | 31.4 | ||
| 18 December 2024 | $25.21 | 43.8 | 54.4 | 9.6 | 12.8 | 23.5 | ||
| 18 April 2024 | $23.10 | 155.3 | 28.8 | 36.9 | 50.6 | 39.2 | ||
| 18 March 2024 | $25.10 | 8.8 | 10.7 | 13.2 | 17.7 | |||
| 18 October 2023 | $20.40 | 52.8 | 64.0 | 85.1 | 109.7 | 228.1 | ||
| 15 September 2023 | $22.14 | 22.7 | 27.3 | 35.1 | 47.8 | 92.0 | ||
| 08 August 2023 | $23.34 | 15.1 | 17.5 | 22.1 | 29.4 | |||
| 05 July 2023 | $24.05 | 11.1 | 13.4 | 16.9 | 22.1 | |||
| 22 February 2023 | $25.05 | 26.4 | 7.1 | |||||
The data for iShares Neuroscience & Healthcare (exchange: ARCX symbol: IBRN) was last updated 04 Mar 2026 14:49. Data for this ETF is available from 26 Aug 2022 - 03 Mar 2026.